Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lavandula coronopifolia petroleum ether extract is a botanical extract derived from the plant *Lavandula coronopifolia* (a species of lavender) using petroleum ether as the extraction solvent. It has been investigated for its potential anticancer properties, specifically against human breast carcinoma cell lines like MDA-MB-231. In vitro studies have demonstrated that the extract induces concentration-dependent cytotoxicity and morphological changes in cancer cells, although it appears less potent than other solvent extracts (such as chloroform or ethyl acetate) from the same plant. The specific bioactive compounds and molecular mechanisms of action responsible for its cytotoxic effects remain to be fully elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lavandula coronopifolia petroleum ether extract.